A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer April 2020 20(2):89-97 - Subject
- Language
- ISSN
- 1526-8209